{"news_desk": "National", "print_page": "15", "section_name": "U.S.", "subsection_name": null, "byline": {"contributor": "Andrew Pollack contributed reporting.", "original": "By STEPHANIE SAUL", "person": [{"rank": 1, "role": "reported", "firstname": "Stephanie", "organization": "", "lastname": "SAUL"}]}, "abstract": "Interview with incoming Stanford University president Marc Tessier-Lavigne reveals that his position on board of biotech company Juno Therapeutics will be reviewed to make sure no conflicts of interest exist.", "type_of_material": "News", "word_count": "730", "lead_paragraph": "Marc Tessier-Lavigne, who will leave Rockefeller University to lead Stanford University, has also worked as an executive in the biotech industry,", "pub_date": "2016-02-06T00:00:00Z", "document_type": "article", "slideshow_credits": null, "headline": {"main": "New Stanford President Has Biotech Connection ", "print_headline": "New Stanford President Has Biotech Connection "}, "snippet": "Marc Tessier-Lavigne, who will leave Rockefeller University to lead Stanford University, has also worked as an executive in the biotech industry,", "multimedia": [], "web_url": "http://www.nytimes.com/2016/02/06/us/marc-tessier-lavigne-new-stanford-president.html", "keywords": [{"rank": "1", "is_major": "Y", "value": "Tessier-Lavigne, Marc", "name": "persons"}, {"rank": "2", "is_major": "Y", "value": "Colleges and Universities", "name": "subject"}, {"rank": "3", "is_major": "Y", "value": "Juno Therapeutics Inc", "name": "organizations"}, {"rank": "4", "is_major": "N", "value": "Rockefeller University", "name": "organizations"}, {"rank": "5", "is_major": "N", "value": "Appointments and Executive Changes", "name": "subject"}, {"rank": "6", "is_major": "N", "value": "Biotechnology and Bioengineering", "name": "subject"}, {"rank": "7", "is_major": "Y", "value": "Stanford University", "name": "organizations"}], "blog": [], "_id": "56b5547a38f0d86b498f99da", "source": "The New York Times"}